您当前所在的位置:首页 > 产品中心 > 产品信息
Daptomycin_分子结构_CAS_103060-53-3)
点击图片或这里关闭

Daptomycin

产品号 D2446 公司名称 Sigma Aldrich
CAS号 103060-53-3 公司网站 http://www.sigmaaldrich.com
分子式 C72H101N17O26 电 话 1-800-521-8956
分子量 1620.67064 传 真
纯 度 ≥90% (HPLC) 电子邮件
保 存 Chembase数据库ID: 154366

产品价格信息

请登录

产品别名

标题
Daptomycin
IUPAC标准名
(3S)-3-{[(3S,6S,9R,15S,18R,21S,24R,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]carbamoyl}-3-[(2R)-3-carbamoyl-2-[(2S)-2-decanamido-3-(1H-indol-3-yl)propanamido]propanamido]propanoic acid
IUPAC传统名
(3S)-3-{[(3S,6S,9R,15S,18R,21S,24R,30S,31R)-3-[2-(2-aminophenyl)-2-oxoethyl]-24-(3-aminopropyl)-15,21-bis(carboxymethyl)-6-[(2R)-1-carboxypropan-2-yl]-9-(hydroxymethyl)-18,31-dimethyl-2,5,8,11,14,17,20,23,26,29-decaoxo-1-oxa-4,7,10,13,16,19,22,25,28-nonaazacyclohentriacontan-30-yl]carbamoyl}-3-[(2R)-3-carbamoyl-2-[(2S)-2-decanamido-3-(1H-indol-3-yl)propanamido]propanamido]propanoic acid
别名
Dapcin

产品登记号

CAS号 103060-53-3

产品性质

Empirical Formula (Hill Notation) C72H101N17O26
纯度 ≥90% (HPLC)
溶解度 DMSO: soluble
溶解度 ethanol: soluble
溶解度 methanol: soluble
MSDS下载 下载链接
保存温度 -20°C
德国WGK号 3

产品详细信息

详细说明 (English)
Biochem/physiol Actions
Cyclic lipopeptide antibiotic effective against gram-positive bacteria. Derived from a fermentation product of Streptomyces sp. Its distinct mechanism of action, disrupting plamsa membrane function, makes it useful against resistant bacteria. Potential therapy for Staphylococcus aureus infections, including MRSA (methicillin-resistant Staphylococcus aureus).
Daptomycin disrupts plasma membrane function, which makes it useful against resistant bacteria. It is thought to cause rapid depolarization thereby inhibiting protein, DNA and RNA synthesis.
Application
Daptomycin is a cyclic lipopeptide antibiotic effective against gram-positive bacteria. It is derived from a fermentation product of Streptomyces sp. It is useful against resistant bacteria. It is a potential therapy for Staphylococcus aureus infections1, including MRSA (methicillin-resistant Staphylococcus aureus). It has also been studied as a potential therapy for Streptococcus pneumoniae infections 2. It has been used to study the impact of sarA on daptomycin susceptibility of Staphylococcus aureus.3
详细说明 (简体中文)
Biochem/physiol Actions
Cyclic lipopeptide antibiotic effective against gram-positive bacteria. Derived from a fermentation product of Streptomyces sp. Its distinct mechanism of action, disrupting plamsa membrane function, makes it useful against resistant bacteria. Potential therapy for Staphylococcus aureus infections, including MRSA (methicillin-resistant Staphylococcus aureus).
Daptomycin disrupts plasma membrane function, which makes it useful against resistant bacteria. It is thought to cause rapid depolarization thereby inhibiting protein, DNA and RNA synthesis.
Application
Daptomycin is a cyclic lipopeptide antibiotic effective against gram-positive bacteria. It is derived from a fermentation product of Streptomyces sp. It is useful against resistant bacteria. It is a potential therapy for Staphylococcus aureus infections1, including MRSA (methicillin-resistant Staphylococcus aureus). It has also been studied as a potential therapy for Streptococcus pneumoniae infections 2. It has been used to study the impact of sarA on daptomycin susceptibility of Staphylococcus aureus.3

参考文献